Posted by Michael Wonder on 17 Jun 2017
U.S. FDA approves Humalog Junior KwikPen for the treatment of diabetes
13 June 2017 - The U.S. FDA approved Eli Lilly and Company’s Humalog Junior KwikPen for the treatment of diabetes.
Humalog Junior KwikPen is a pre-filled pen with half-unit dosing capability, enabling finer dose adjustment for those who need it.
Humalog Junior KwikPen will be available in U.S. pharmacies later this year. Lilly also has a pending application for Humalog Junior KwikPen regulatory approval in the European Union.
